[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # Celldex Therapeutics, Inc (CLDX) Celldex Therapeutics initiates global Phase X program for barzolvolimab in cold urticaria. Stock hits a 52-week high amid positive trial data and analyst upgrades. ### About Celldex Therapeutics, Inc Celldex Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases. Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Celldex Therapeutics, Inc (CLDX) trading volume is up XXXXXX% from the previous week. - Celldex Therapeutics, Inc (CLDX) social dominance is up XXXXX% from the previous month. - Celldex Therapeutics, Inc (CLDX) posts created is up XXXXXX% from the previous month. - Celldex Therapeutics, Inc Price hit a 52-Week high of $XXXXX for the hour ### Price: $XXXXX  [Price 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/close.tsv) The stock's price action is bullish, reaching a 52-week high due to positive trial data and analyst upgrades, but concerns about recent net losses and price volatility are tempering this upward trend. 24-Hour: -XXXX% 7-Day: XXXXX% 30-Day: XXXXX% 1-Year High: $XXXXX on 2025-12-10 1-Year Low: $XXXXX on 2025-04-08 ### AltRank: XXXXX  [AltRank 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/alt_rank.tsv) Celldex Therapeutics, Inc (CLDX) is currently AltRank #1,349 based on combined combined social and market metrics Daily Average: XXXXX X Week: XXXXX -XXX X Month: XXXXX -X X Months: XXXXX +13 X Year: XXXXX +95 1-Year High: XXXXX on 2025-09-04 1-Year Low: XX on 2024-12-28 ### Galaxy Score: XXXXX  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/galaxy_score.tsv) Current Value: XXXXX Daily Average: XX X Week: XX -XX X Month: XX +7 X Months: XX -XX X Year: XX -X 1-Year High: XX on 2025-04-11 1-Year Low: X on 2025-08-28 ### Engagements: XXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/interactions.tsv) Current Value: XXXXX Daily Average: XXXXX X Week: XXXXX -XX% X Month: XXXXXX +40% X Months: XXXXXXX +60% X Year: XXXXXXXXX -XX% 1-Year High: XXXXXX on 2025-06-13 1-Year Low: XX on 2025-04-13 Engagements by network (24h): X: XXXXX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/posts_active.tsv) Current Value: XX Daily Average: XX X Week: XXX -XX% X Month: XXX +55% X Months: XXXXX +88% X Year: XXXXX +42% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-04-13 Mentions by network (24h): X: XX ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX X Week: XX -XX% X Month: XXX +44% X Months: XXXXX +217% X Year: XXXXX +65% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-04-13 The most influential creators that mention Celldex Therapeutics, Inc in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BuyTheUgly](/creator/twitter/BuyTheUgly) | X | XX | X | XXX | | [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | X | XXX | X | XXX | | [@doepke_michel](/creator/twitter/doepke_michel) | X | XXXXX | X | XX | | [@BullBearInvests](/creator/twitter/BullBearInvests) | X | XX | X | XX | | [@seedytx19](/creator/twitter/seedytx19) | X | XXXXX | X | XX | | [@Hassa51248](/creator/twitter/Hassa51248) | X | XX | X | XX | | [@SteveDJacobs](/creator/twitter/SteveDJacobs) | X | XXXXX | X | XX | | [@JaksonMika78723](/creator/twitter/JaksonMika78723) | X | XX | X | XX | [View More](/list/creators/$cldx/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% -XX% X Month: XX% -XX% X Months: XX% -XX% X Year: XX% -XX% 1-Year High: XXX% on 2024-12-12 1-Year Low: XX% on 2025-05-10 Most Supportive Themes: - Positive Trial Data and Biotech Momentum: (35%) Posts highlight positive trial data for Celldex's therapies and the overall positive momentum within the biotech sector, suggesting optimism for Celldex Therapeutics. - Analyst Ratings and Price Targets: (25%) Mentions of analyst ratings and price targets, with some analysts reiterating 'Buy' ratings and setting higher price targets for CLDX. - Product Advancements and Partnerships: (15%) News about advancements in treatments like Dupixent and partnerships, indicating potential growth and market expansion for Celldex. Most Critical Themes: - Price Volatility and Market Cap Concerns: (10%) Some posts mention the stock's volatility and the current market cap, with one post suggesting the stock is being 'pumped' and could be a meme stock. ### Social Dominance: XXXXXXX%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/social_dominance.tsv) Current Value: XXXXXXX% Daily Average: XXXXXXX% X Week: XXXXXX% +0.002% X Month: XXXXX% +0.0074% X Months: XXXXX% -XXXXXX% X Year: XXXXX% +0.0032% 1-Year High: XXXXX% on 2024-12-21 1-Year Low: XXXXXX% on 2025-10-18 ### Market Dominance: XXXXXXX%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/market_dominance.tsv) Current Value: XXXXXXX% Daily Average: X% 1-Year High: XXXXX% on 2025-12-08 1-Year Low: XXXXXXX% on 2025-03-19 ### Market Cap: $XXXXXXXXXXXXX  [Market Cap 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/market_cap.tsv) Current Value: $XXXXXXXXXXXXX Daily Average: $XXXXXXXXXXXXX X Week: $XXXXXXXXXXXXX +$5.30% X Month: $XXXXXXXXXXXXX +$23% X Months: $XXXXXXXXXXXXX +$38% X Year: $XXXXXXXXXXXXX +$6.60% 1-Year High: $XXXXXXXXXXXXX on 2025-12-08 1-Year Low: $XXXXXXXXXXXXX on 2025-04-08 ### Top Celldex Therapeutics, Inc Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS" [X Link](https://x.com/BuyTheUgly/status/1998485125680738411) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:09Z XX followers, XXX engagements "Stock market watchlist #1 $RUBI #2 $ASST#3 $FGL #4 $RELI #5 $VNRX #6 $IVP #7 $CHR #8 $BNED#9 $CMND $SMMT $CPRX $CRMD $HUMA $MREO $TCRX $SCPL $VTGN $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL" [X Link](https://x.com/ParadiseTraderr/status/1998484362669768941) [@ParadiseTraderr](/creator/x/ParadiseTraderr) 2025-12-09T20:06Z XXX followers, XXX engagements "$CLDX -XXXX% today as Celldex Initiates Global Registrational Phase X Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422020934062557) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T15:58Z 3009 followers, XX engagements "Santa rally starts here $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS" [X Link](https://x.com/BuyTheUgly/status/1998059318739194147) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-08T15:57Z XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Celldex Therapeutics initiates global Phase X program for barzolvolimab in cold urticaria. Stock hits a 52-week high amid positive trial data and analyst upgrades.
Celldex Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases.
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock's price action is bullish, reaching a 52-week high due to positive trial data and analyst upgrades, but concerns about recent net losses and price volatility are tempering this upward trend.
24-Hour: -XXXX% 7-Day: XXXXX% 30-Day: XXXXX%
1-Year High: $XXXXX on 2025-12-10
1-Year Low: $XXXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Celldex Therapeutics, Inc (CLDX) is currently AltRank #1,349 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX -XXX
X Month: XXXXX -X
X Months: XXXXX +13
X Year: XXXXX +95
1-Year High: XXXXX on 2025-09-04
1-Year Low: XX on 2024-12-28
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX +7
X Months: XX -XX
X Year: XX -X
1-Year High: XX on 2025-04-11
1-Year Low: X on 2025-08-28
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX +40%
X Months: XXXXXXX +60%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-06-13
1-Year Low: XX on 2025-04-13
Engagements by network (24h): X: XXXXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +55%
X Months: XXXXX +88%
X Year: XXXXX +42%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX +44%
X Months: XXXXX +217%
X Year: XXXXX +65%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-13
The most influential creators that mention Celldex Therapeutics, Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BuyTheUgly | X | XX | X | XXX |
| @ParadiseTraderr | X | XXX | X | XXX |
| @doepke_michel | X | XXXXX | X | XX |
| @BullBearInvests | X | XX | X | XX |
| @seedytx19 | X | XXXXX | X | XX |
| @Hassa51248 | X | XX | X | XX |
| @SteveDJacobs | X | XXXXX | X | XX |
| @JaksonMika78723 | X | XX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-12
1-Year Low: XX% on 2025-05-10
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% +0.002%
X Month: XXXXX% +0.0074%
X Months: XXXXX% -XXXXXX%
X Year: XXXXX% +0.0032%
1-Year High: XXXXX% on 2024-12-21
1-Year Low: XXXXXX% on 2025-10-18
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-12-08
1-Year Low: XXXXXXX% on 2025-03-19
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$5.30%
X Month: $XXXXXXXXXXXXX +$23%
X Months: $XXXXXXXXXXXXX +$38%
X Year: $XXXXXXXXXXXXX +$6.60%
1-Year High: $XXXXXXXXXXXXX on 2025-12-08
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"
X Link @BuyTheUgly 2025-12-09T20:09Z XX followers, XXX engagements
"Stock market watchlist #1 $RUBI #2 $ASST#3 $FGL #4 $RELI #5 $VNRX #6 $IVP #7 $CHR #8 $BNED#9 $CMND $SMMT $CPRX $CRMD $HUMA $MREO $TCRX $SCPL $VTGN $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL"
X Link @ParadiseTraderr 2025-12-09T20:06Z XXX followers, XXX engagements
"$CLDX -XXXX% today as Celldex Initiates Global Registrational Phase X Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism More Info:"
X Link @OzmosiHealth 2025-12-09T15:58Z 3009 followers, XX engagements
"Santa rally starts here $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"
X Link @BuyTheUgly 2025-12-08T15:57Z XX followers, XXX engagements
/topic/$cldx